Effects of hydrogen peroxide, nitric oxide and antioxidants on NF-κB

Redox Report

Volumn 2, Issue 4, 1996, Pages 249-256

  Moormann, A M ^a   Koenig, R J ^b   Meshnick, S R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000830093     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1080/13510002.1996.11747057     Document Type: Article

References (29)

1. Baeuerle P A, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 1988; 53: 211-217.
2. Baeuerle P A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072: 63-80.
3. Baeuerle P A, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-179.
4. Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 1993; 74: 887-898.
5. Finco T S, Baldwin A S Jr. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J Biol Chem 1993; 268: 17676-17679.
6. Kowalik T F, Wing B, Haskill J S, Azizkhan J C, Baldwin A S Jr, Huang E S. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 1993; 90: 1107-1111.
7. Betts J C, Agranoff A B, Nabel G J, Shayman J A. Dissociation of endogenous cellular ceramide from NF-kappa B activation. J Biol Chem 1994; 269: 8455-8458.
8. Nabel G J. HIV. Tampering with transcription [news; comment]. Nature 1991; 350: 658.
9. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
10. Link E, Kerr L D, Schreck R, Zabel U, Verma I, Baeuerle P A. Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem 1992; 267: 239-246.
11. Finco T S, Beg A A, Baldwin A S Jr. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 1994; 91: 11884-11888.
12. Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 1990; 344: 678-682.
13. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle P A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993; 365: 182-185.
14. Perkins N D, Schmid R M, Duckett C S, Leung K, Rice N R, Nabel G J. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 1992; 89: 1529-1533.
15. Meyer M, Pahl H L, Baeuerle P A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact 1994; 91: 91-100.
16. Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258.
17. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 2005-2015.
18. Staal F J, Roederer M, Herzenberg L A, Herzenberg L A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990; 87: 9943-9947.
19. Kalebic T, Kinter A, Poli G, Anderson M E, Meister A, Fauci A S. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N- acetylcysteine. Proc Natl Acad Sci USA 1991; 88: 986-990.
20. Menon S D, Qin S, Guy G R, Tan Y H. Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation. J Biol Chem 1993; 268: 26805-26812.
21. Israel N, Gougerot-Pocidalo M A, Aillet F, Virelizier J L. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992; 149: 3386-3393.
22. Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 1993; 268: 11380-11388.
23. Kumar S, Rabson A B, Gelinas C. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v- Reloncoprotein. Mol Cell Biol 1992; 12: 3094-3106.
24. Anderson M T, Staal F J, Gitler C, Herzenberg L A, Herzenberg L A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci USA 1994; 91: 11527-11531.
25. Meshnick S R. Free radicals and antioxidants [letter]. Lancet 1994; 344: 1441-1442.
26. Perkins N D, Edwards N L, Duckett C S, Agranoff A B, Schmid R M, Nabel G J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J 1993; 12: 3551-3558.
27. Liu J, Perkins N D, Schmid R M, Nabel G J. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J Virol 1992; 66: 3883-3887.
28. Leung K, Nabel G J. HTLV-I transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 1988; 333: 776-778.
29. Marletta M A. Nitric oxide, nitrovasodilators, and L-arginine - an unusual relationship [editorial]. West J Med 1991: 154: 107-109.